Veru Inc EV/EBIT
What is the EV/EBIT of Veru Inc?
The EV/EBIT of Veru Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Veru Inc
What does Veru Inc do?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Companies with ev/ebit similar to Veru Inc
- Eastower Wireless Inc has EV/EBIT of N/A
- Silo Pharma Inc has EV/EBIT of N/A
- TOMI Environmental Solutions has EV/EBIT of N/A
- Quebec Precious Metals has EV/EBIT of N/A
- Rivian Automotive has EV/EBIT of N/A
- Prevail Therapeutics Inc has EV/EBIT of N/A
- Veru Inc has EV/EBIT of N/A
- Aziyo Biologics has EV/EBIT of N/A
- Hyve Plc has EV/EBIT of N/A
- Hyve Plc has EV/EBIT of N/A
- Sherpa II has EV/EBIT of N/A
- Trean Insurance has EV/EBIT of N/A
- Lumos Pharma Inc has EV/EBIT of N/A